Tag: Cagrilintide/semaglutide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cagrilintide/semaglutide

Novo Nordisk, U.S. Biotech Company Team Up to Create Obesity Pills - SW Iowa News

Added to Collection on: 2025-05-16 15:55:31

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Intestinal hormones
Novo Nordisk
Anti-obesity medication
Semaglutide
Glucagon-like peptide-1
Eli Lilly and Company
G protein-coupled receptor
Cagrilintide/semaglutide
SEPTERNA

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk is losing Canadian patent protection on a blockbuster drug after not paying a small fee

Added to Collection on: 2025-06-17 21:08:47

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
In Denmark
In science
Semaglutide
Novo Nordisk
Generic drug
Sandoz
Pharmaceutical industry
Patent
Nordisk
Cagrilintide/semaglutide
Canada

Click the tags to see associated articles and topics

View Article Details
Supercede Therapeutics Provides Update on Novel Oral Treatment for Obesity

Added to Collection on: 2025-06-25 12:51:45

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Obesity
In Denmark
Semaglutide
Myostatin
Weight loss
Adipose tissue
Diabetes
Eli Lilly and Company
Anti-obesity medication
Cagrilintide/semaglutide
Supercede Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
U.S. Peptide Therapeutics (Retail Side) Market Report 2033

Added to Collection on: 2025-08-08 08:16:43

Tags for this article:

PEPTIDE THERAPEUTICS
GLP-1 receptor agonists
Peptide hormones
Anti-diabetic drugs
Lipopeptides
Semaglutide
Glucagon-like peptide-1
Anti-obesity medication
Cagrilintide/semaglutide
Hims & Hers Health
Cagrilintide
Eli Lilly and Company
United States

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk: Undervalued Pharma Heavyweight With Upside Potential - AInvest

Added to Collection on: 2025-08-24 14:42:34

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Novo Nordisk
Anti-diabetic drugs
Semaglutide
Eli Lilly and Company
Cagrilintide/semaglutide
Glucagon-like peptide-1
Catalent
Eli Lilly
Amycretin

Click the tags to see associated articles and topics

View Article Details
We're reading about dueling data from Lilly and Novo, a Roche deal - STAT News

Added to Collection on: 2025-09-18 19:14:00

Tags for this article:

GLP-1 receptor agonists
Peptide hormones
PEPTIDE THERAPEUTICS
Lipopeptides
Anti-diabetic drugs
Semaglutide
Eli Lilly and Company
Novo Nordisk
Tirzepatide
Glucagon-like peptide-1
Diabetes
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk REACH Study Shows Ozempic Reduces Cardiovascular Risk by 23 ...

Added to Collection on: 2025-09-20 14:48:46

Tags for this article:

PEPTIDE THERAPEUTICS
GLP-1 receptor agonists
Peptide hormones
Anti-diabetic drugs
Lipopeptides
Semaglutide
Cagrilintide/semaglutide
Dulaglutide
Cagrilintide
Novo Nordisk
Glucagon-like peptide-1
Diabetes

Click the tags to see associated articles and topics

View Article Details
Novo Nordisk: A Guru Buy Amid the Selloff -- Do LEAPS Make Sense? - TradingView

Added to Collection on: 2025-09-21 22:19:07

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Peptide hormones
Lipopeptides
Anti-diabetic drugs
Semaglutide
Novo Nordisk
Cagrilintide/semaglutide
Eli Lilly and Company
Anti-obesity medication
Tirzepatide
Glucagon-like peptide-1

Click the tags to see associated articles and topics

View Article Details
Ascletis' Muscle-Preserving Weight Loss Drug Candidate Displayed Significant ...

Added to Collection on: 2025-09-26 00:55:11

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Lipopeptides
Peptide hormones
Semaglutide
Anti-obesity medication
Metabolic dysfunction–associated steatotic liver disease
Medroxyprogesterone acetate
Metabolic syndrome
Weight loss
Magnesium in biology
Cagrilintide/semaglutide
Ascletis Pharma Inc.
Adobe
Ascletis Pharma

Click the tags to see associated articles and topics

View Article Details
Here's Why Morgan Stanley Analysts Downgraded Novo Nordisk's Stock - Investopedia

Added to Collection on: 2025-09-29 17:56:25

Tags for this article:

Peptide hormones
Anti-diabetic drugs
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Novo Nordisk
Semaglutide
Anti-obesity medication
Glucagon-like peptide-1
Eli Lilly and Company
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Book a Demo